PharmaNet Group Ltd. reported consolidated earnings results for the half year ended December 31, 2012. For the period, the company reported revenue of AUD 284,100 compared to AUD 24,086 a year ago. Loss before income tax was AUD 910,122 compared to AUD 1,588,526 a year ago. Loss for the period was AUD 910,122 compared to AUD 1,588,526 a year ago. Loss for the period attributable to members of the parent entity was AUD 890,481 or 0.06 cents basic and diluted per share compared to AUD 1,572,421 or 0.13 cents basic and diluted per share a year ago. Net cash flows used in operating activities was AUD 994,988 compared to AUD 1,777,561 a year ago. Payments for plant and equipment were AUD 12,307 compared to AUD 6,760 a year ago. Net tangible assets per share were 0.01 cents compared to 0.04 cents a year ago.

PharmaNet Group Ltd. announced that they will report first half, 2013 results on Feb 28, 2013

PharmaNet Group Ltd., Annual General Meeting, Nov 28, 2012., at 10:00 W. Australia Standard Time. Location: Doig Room, Patersons Stadium. Agenda: To receive and consider the financial statements and reports of the directors and the auditors for the year ended June 30, 2012; to approve adoption of remuneration report; to approve re-election of Mr. John Found as director; and to approve of additional 10% placement facility.